These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 38945356)
1. For your consideration: Benefits of listing as willing to consider heart offers from donors with hepatitis C. Ruck JM; Rodriguez E; Zhou AL; Durand CM; Massie AB; Segev DL; Polanco A; Bush EL; Kilic A J Thorac Cardiovasc Surg; 2024 Jun; ():. PubMed ID: 38945356 [TBL] [Abstract][Full Text] [Related]
2. To decline or not to decline: Consequences of decision-making regarding lung offers from donors with hepatitis C. Ruck JM; Bowring MG; Durand CM; Ha JS; Massie AB; Segev DL; Merlo CA; Bush EL J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1967-1976.e2. PubMed ID: 37678605 [TBL] [Abstract][Full Text] [Related]
3. Utilization and outcomes of expanded criteria donors in adults with congenital heart disease. Akbar AF; Zhou AL; Ruck JM; Kilic A; Cedars AM J Heart Lung Transplant; 2024 Oct; 43(10):1691-1700. PubMed ID: 38897425 [TBL] [Abstract][Full Text] [Related]
4. Center and Individual Willingness to Consider Heart and Lung Offers From Donors With Hepatitis C. Ruck JM; Bowring MG; Zeiser LB; Durand CM; Massie AB; Segev DL; Kilic A; King EA; Bush EL J Surg Res; 2024 Oct; 302():175-185. PubMed ID: 39098116 [TBL] [Abstract][Full Text] [Related]
5. Outcomes following concomitant multiorgan heart transplantation from circulatory death donors: The United States experience. Zhou AL; Rizaldi AA; Akbar AF; Ruck JM; King EA; Kilic A J Heart Lung Transplant; 2024 Aug; 43(8):1252-1262. PubMed ID: 38548240 [TBL] [Abstract][Full Text] [Related]
6. Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney. Shelton BA; Sawinski D; Mehta S; Reed RD; MacLennan PA; Locke JE Transpl Infect Dis; 2018 Apr; 20(2):e12829. PubMed ID: 29277956 [TBL] [Abstract][Full Text] [Related]
7. Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients. Sageshima J; Troppmann C; McVicar JP; Santhanakrishnan C; de Mattos AM; Perez RV Transplantation; 2018 Jul; 102(7):1179-1187. PubMed ID: 29953423 [TBL] [Abstract][Full Text] [Related]
8. Mid-term Waitlist and Posttransplant Outcomes With Hepatitis C-positive Donor Hearts. Hong Y; Couper CD; Iyanna N; Hess NR; Ziegler LA; Abdullah M; Mathier MA; Hickey GW; Keebler ME; Silvestry SC; Kaczorowski D Transplantation; 2024 Sep; ():. PubMed ID: 39228015 [TBL] [Abstract][Full Text] [Related]
9. Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist. Choi AY; Mulvihill MS; Lee HJ; Zhao C; Kuchibhatla M; Schroder JN; Patel CB; Granger CB; Hartwig MG JAMA Cardiol; 2020 Jun; 5(6):660-668. PubMed ID: 32293647 [TBL] [Abstract][Full Text] [Related]
10. Trends and three-year outcomes of hepatitis C virus-viremic donor heart transplant for hepatitis C virus-seronegative recipients. Ruck JM; Zhou AL; Zeiser LB; Alejo D; Durand CM; Massie AB; Segev DL; Bush EL; Kilic A JTCVS Open; 2022 Dec; 12():269-279. PubMed ID: 36590744 [TBL] [Abstract][Full Text] [Related]
11. HCV-Positive Allograft Use in Heart Transplantation Is Associated With Increased Access to Overdose Donors and Reduced Waitlist Mortality Without Compromising Outcomes. Altshuler PJ; Helmers MR; Schiazza AR; Hu R; Han JJ; Herbst DA; Iyengar A; Atluri P J Card Fail; 2022 Jan; 28(1):32-41. PubMed ID: 34314824 [TBL] [Abstract][Full Text] [Related]
12. The impact of using hepatitis c virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate. Gernhofer YK; Brambatti M; Greenberg BH; Adler E; Aslam S; Pretorius V J Heart Lung Transplant; 2019 Nov; 38(11):1178-1188. PubMed ID: 31492607 [TBL] [Abstract][Full Text] [Related]
13. Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation. Couri T; Katz J; Stoeckle K; Nugooru A; Yeh H; Chung R; Paul S Am J Nephrol; 2019; 50(3):168-176. PubMed ID: 31390615 [TBL] [Abstract][Full Text] [Related]
14. Association of high-priority exceptions with waitlist mortality among heart transplant candidates. Johnson DY; Ahn D; Lazenby K; Zeng S; Zhang K; Narang N; Khush K; Parker WF J Heart Lung Transplant; 2023 Sep; 42(9):1175-1182. PubMed ID: 37225029 [TBL] [Abstract][Full Text] [Related]
15. Use of Hepatitis C Positive Organs: Patient Attitudes in Urban Chicago. Couri T; Cotter TG; Chen D; Hammes M; Reddy B; Josephson M; Yeh H; Chung RT; Paul S Am J Nephrol; 2019; 49(1):32-40. PubMed ID: 30554209 [TBL] [Abstract][Full Text] [Related]
16. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey. Shaffer AA; Thomas AG; Bowring MG; Van Pilsum Rasmussen SE; Cash A; Kucirka LM; Alqahtani SA; Gurakar A; Sulkowski MS; Cameron AM; Segev DL; Durand CM Transpl Infect Dis; 2018 Dec; 20(6):e12982. PubMed ID: 30144258 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients. Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982 [TBL] [Abstract][Full Text] [Related]
18. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study. Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882 [TBL] [Abstract][Full Text] [Related]